Azienda Ospedaliero Universitaria Ospedali Riuniti Umberto I G M Lancisi G Salesi — Clinical Trial Site

39 Registered trials

20 Currently recruiting

Organisation

Azienda Ospedaliero Universitaria Ospedali Riuniti Umberto I G M Lancisi G Salesi

Location

Ancona, Italy

Identifier

ORG-100030367

Address

Via Filippo Corridoni 11, 60123, Italy

Departments

Anestesia e Rianimazione
Clinica di Ematologia
Clinica di Oncologia Medica
Clinica Ematologica
Clinical Oncology
Department of Oncohematology
DIPARTIMENTO DI EMATOLOGIA
DIPARTIMENTO DI MEDICINA INTERNA
DIPARTIMENTO DI MEDICINA INTERNA - SOD CLINICA EMATOLOGICA
DISCO
Gobbi
Hematology Department
Medicina sperimentale e clinica, clinica oculistica
N/A
Neonatology
Oncoematologia Pediatrica
Oncologia Medica
Pediatric Oncohematology
Respiratory Medicine Unit
S.O.D. Clinica Oncologica
Scienze cardiovascolari
SOC della Clinica di Ematologia
SOD clinica di endocrinologia e malattie del metabolismo
SOD Clinica Ematologica
SOD Neuropsichiatria Infantile
SOS Oncoematologia Pediatrica
SOSD Oncoematologia Pediatrica
U. O. di Pneumologia

Clinical trials at this site (39)

Search interface

SIOP PNET 5 medulloblastoma Pending

2024-513724-42-00 Medulloblastoma 10
Phase II Prospective Multicenter Study of High-Dose Treosulfan/Melphalan as Consolidation Treatment in Newly Diagnosed High-Risk and Very Hi… Pending

2024-518912-37-01 Ewing Sarcoma 4
Prospective Phase II study on Safety and Efficacy of Fludarabine plus Treosulfan (14g) (FT14) conditioning regimen for allogeneic Stem Cell … Pending

2024-520326-11-00 Acute Myeloid Leukemia (AML) 4
A study evaluating the effects of filgotinib in children and teenagers with ulcerative colitis Recruiting

2024-511458-32-00 Ulcerative colitis 5 2025-06-15
CAPRI-3 Phase 3 clinical study to evaluate the use of continuing cetuximab treatment beyond first line progression in molecular selected met… Recruiting

2024-519322-20-00 metastatic colorectal cancer 5 2025-07-21
A Study to Determine Safety and Long-Term Effectiveness of Faricimab in Participants with Age-Related Macular Degeneration Recruiting

2024-517545-13-00 Neovascular Age-Related Macular Degeneration 11 2025-06-04
A phase II randomized clinical study of the combination of avelumab plus cetuximab as rechallenge strategy in pre-treated RAS/BRAF wild type… Recruiting

2024-519481-44-00 colorectal metastatic cancer 4 2025-01-08
HR-NBL2: High-risk neuroblastoma study 2.0 of SIOP-Europe- Neuroblastoma/SIOPEN: Randomised, international and multicentric phase 3 study t… Recruiting

2024-514917-36-00 Patients with High Risk Neuroblastoma 5 2024-11-21
Efficacy and safety of adjunctive IgM-enriched immunoglobulin therapy with a personalized dose based on serum IgM-titers vs. standard dose i… Recruiting

2024-518096-57-00 Septic shock 5 2024-11-11
Adding Navtemadlin to Ruxolitinib for Patients with Myelofibrosis Recruiting

2023-504724-25-00 Primary Myelofibrosis 5 2024-10-16
A follow-up study to test long-term treatment with BI 1015550 in people with pulmonary fibrosis who took part in a previous study with BI 10… Recruiting

2023-507353-15-00 idiopathic pulmonary fibrosis (IPF) 5 2024-09-10
A study to investigate efficacy, safety, and tolerability of mavorixafor in participants with congenital and acquired primary autoimmune and… Recruiting

2023-508482-32-00 Neutropenias 5 2024-07-22
Randomized phase 3 study of intermittent or continuous Panitumumab plus FOLFIRI for first-line treatment of patients with unresectable left … Recruiting

2023-509551-14-00 Unresectable left sided RAS/B-RAF wild-type metastatic 5 2024-06-12
VEMURAFENIB PLUS RITUXIMAB AS A CHEMOTHERAPY-FREE ALTERNATIVE TO CLADRIBINE FOLLOWED BY MRD-GUIDED RITUXIMAB IN FRONT-LINE HAIRY CELL LEUKEM… Recruiting

2024-520119-41-00 Previously untreated patients with diagnosis of HCL 4 2023-01-15
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone versus Lenalidomide Alone in Participants With Newly Dia… Recruiting

2023-510384-36-00 Newly Diagnosed Multiple Myeloma 5 2022-09-13
Temozolomide and irinotecan consolidation in patients with MGMT silenced, microsatellite stable colorectal cancer with persistence of minima… Recruiting

2024-515681-14-00 Stage II (pT4)/III colorectal cancer with positive circ 4 2022-05-02
SIOP-HRMB: An international prospective trial on clinically high-risk medulloblastoma (HR-MB) in patients older than 3 years. Recruiting

2024-510578-25-00 Histologically proven high-risk medulloblastoma, with a 5 2021-11-05
Comparison between single and dual therapy with drugs that inhibits platelet aggregation in patient undergoing the percutaneous left atrial … Recruiting

2024-515361-34-00 Patients with atrial fibrillation undergoing percutaneo 6 2021-10-13
Investigate the efficacy and safety of a bio-marker driven cetuximab-based treatment regimen over 3 treatment lines in mCRC patients with RA… Recruiting

2024-518534-81-00 metastatic colorectal cancer 4 2021-07-01
The study is aimed at evaluating the feasibility of a hypomethylating treatment combined with hematopoietic stem cell transplantation in com… Recruiting

2023-510515-19-00 Higher-risk-myelodysplastic syndromes 5 2020-11-27
Study to determine the efficacy of Gemtuzumab Ozogamicin, together with standard chemotherapy, on minimal residual disease levels, in adult … Recruiting

2023-510433-29-00 Favorable-intermediate-risk Acute Myeloid Leukemia 5 2020-09-24
Phase II randomized trial comparing atezolizumab versus atezolizumab plus bevacizumab as first-line treatment in PD-L1 high advanced non-sm… Recruiting

2024-517200-10-00 Advanced non-small-cell lung cancer 4 2020-01-31
Trial aimed at examinate the functionality and effectiveness of the drug "IO" in adult patients with a rare form of cancer that affect the c… Recruiting

2023-510516-39-00 Acute B-cell Lymphoblastic Leukemia with minimal residu 4 2019-10-30
A trial to evaluate efficacy and safety of buloxibutid in people with idiopathic pulmonary fibrosis Ended

2023-509069-19-00 idiopathic pulmonary fibrosis 4 2024-12-12